Analyst Ratings For NASDAQ:AXGN – AxoGen (NASDAQ:AXGN)
Today, Cantor Fitzgerald reiterated its Overweight rating on NASDAQ:AXGN – AxoGen (NASDAQ:AXGN) with a price target of $45.00.
Some recent analyst ratings include
- 5/1/2018-Cantor Fitzgerald Reiterated Rating of Overweight.
- 2/5/2018-William Blair initiated coverage with a Outperform rating.
- 11/21/2017-Wedbush Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:AXGN – AxoGen (NASDAQ:AXGN)
NASDAQ:AXGN – AxoGen (NASDAQ:AXGN) has insider ownership of 7.86% and institutional ownership of 67.62%.
- On 2/20/2018 Jamie Mark Grooms, Director, sold 63,395 with an average share price of $27.67 per share and the total transaction amounting to $1,754,139.65.
- On 2/15/2018 Jamie Mark Grooms, CFO, sold 95,712 with an average share price of $26.84 per share and the total transaction amounting to $2,568,910.08.
- On 2/13/2018 Jamie Mark Grooms, CFO, sold 10,300 with an average share price of $26.21 per share and the total transaction amounting to $269,963.00.
- On 12/12/2017 Jamie Mark Grooms, Director, sold 38,405 with an average share price of $26.35 per share and the total transaction amounting to $1,011,971.75.
- On 12/8/2017 Jamie Mark Grooms, Director, sold 84,295 with an average share price of $26.38 per share and the total transaction amounting to $2,223,702.10.
- On 12/6/2017 Jamie Mark Grooms, Director, sold 21,290 with an average share price of $26.22 per share and the total transaction amounting to $558,223.80.
- On 11/20/2017 Guido J Neels, Director, sold 1,150,000 with an average share price of $19.74 per share and the total transaction amounting to $22,701,000.00.
Recent Trading Activity for NASDAQ:AXGN – AxoGen (NASDAQ:AXGN)
Shares of NASDAQ:AXGN – AxoGen closed the previous trading session at 36.25 down -3.55 8.92% with 262783 shares trading hands.